Current Liabilities
Accounts Payable
Revolution Medicines, Inc. Accounts Payable increased by 24.6% to $80.54M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 69.5%, from $47.51M to $80.54M. Over 5 years (FY 2020 to FY 2025), Accounts Payable shows an upward trend with a 38.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
An increase can indicate better credit terms or increased production volume, while a decrease might suggest faster payments or reduced purchasing.
Detailed definition
The amount of money a company owes to its suppliers and vendors for goods and services purchased on credit. In a large-s...
Peer comparison
Companies with significant supply chain leverage often maintain high payables to maximize their own cash-on-hand.
Metric ID:
accounts_payableHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.44M | $10.49M | $14.06M | $14.17M | $14.07M | $24.38M | $21.31M | $19.91M | $29.78M | $29.63M | $61.79M | $32.38M | $29.32M | $24.46M | $54.43M | $47.51M | $56.76M | $74.85M | $64.62M | $80.54M |
| QoQ Change | — | +0.5% | +34.0% | +0.8% | -0.8% | +73.3% | -12.6% | -6.5% | +49.6% | -0.5% | +108.6% | -47.6% | -9.5% | -16.6% | +122.6% | -12.7% | +19.5% | +31.9% | -13.7% | +24.6% |
| YoY Change | — | — | — | — | +34.8% | +132.4% | +51.6% | +40.5% | +111.7% | +21.5% | +190.0% | +62.6% | -1.6% | -17.5% | -11.9% | +46.7% | +93.6% | +206.1% | +18.7% | +69.5% |
Range$10.44M – $80.54M
CAGR+53.8%
Avg YoY Growth+65.6%
Median YoY Growth+49.1%
Accounts Payable at Other Companies
Frequently Asked Questions
- What is Revolution Medicines, Inc.'s accounts payable?
- Revolution Medicines, Inc. (RVMD) reported accounts payable of $80.54M in Q1 2026.
- How has Revolution Medicines, Inc.'s accounts payable changed year-over-year?
- Revolution Medicines, Inc.'s accounts payable increased by 69.5% year-over-year, from $47.51M to $80.54M.
- What is the long-term trend for Revolution Medicines, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Revolution Medicines, Inc.'s accounts payable has grown at a 38.7% compound annual growth rate (CAGR), from $12.61M to $64.62M.
- What does accounts payable mean?
- The total amount of money the company owes to its suppliers for items it has already received.